Sector portfolio · Investment firm · France

Sanofi's Biotech portfolio

Sanofi has backed 50 Biotech startups in rounds we track, $6.1B between them, shown by the stage each has reached. The best-funded is Advancell.

50startups backed
6stages
$6.1Braised between them
Series Bbiggest stage

Sanofi's whole portfolioSanofi's profile

Series B

18

Stage not reported

11

Series C and later

9

Series A

7

Pre-seed and seed

3

Growth

2

Segment by segment

Series B

18 startups · $2.4B raised

  1. Fulcrum TherapeuticsFulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.United States$310M
  2. Expedition TherapeuticsExpedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024.United States$280M
  3. T-TherapeuticsT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.United Kingdom$279M
  4. Mirador TherapeuticsMirador Therapeutics is a clinical-stage precision medicine company based in San Diego, California.United States$250M
  5. Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$220M
  6. Nura BioNura Bio is a clinical-stage biopharmaceutical company based in South San Francisco, California.United States$142M
  7. Vigil NeuroscienceVigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.United States$130M
  8. NodTheraNodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.United Kingdom$109M

Stage not reported

11 startups · $1.3B raised

  1. DTDice TherapeuticsDice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.United States$345M
  2. MeiraGTxMeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.United States$225M
  3. Q32 BioQ32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.United States$200M
  4. GTGyroscope TherapeuticsGyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.United Kingdom$118M
  5. SAB BiotherapeuticsSAB Biotherapeutics is a clinical-stage biopharmaceutical development company.United States$85M
  6. GravitonGraviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases.United States$75M
  7. AetionAetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.United States$74M
  8. InozymeInozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.United States$60M

Series C and later

9 startups · $1.4B raised

  1. AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M
  2. Electra TherapeuticsElectra Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018.United States$183M
  3. GlycomineGlycomine is an early-stage biotech working on replacement therapies for rare diseases.United States$160M
  4. Click TherapeuticsClick Therapeutics delivers safe and effective digital treatments to patients in need.United States$149M
  5. Escient PharmaceuticalsEscient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.United States$120M
  6. AgomAB TherapeuticsAgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.Belgium$112M
  7. Attovia TherapeuticsAttovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.United States$90M
  8. Epicrispr BiotechnologiesEpicrispr Biotechnologies is a clinical-stage biotechnology company based in South San Francisco, California.United States$90M

Series A

7 startups · $709M raised

  1. Alveus Therapeutics Inc.Alveus Therapeutics Inc is a clinical-stage biotechnology company focused on developing innovative therapies for obesity and metabUnited States$197M
  2. BPBionyra PharmaFrance$165M
  3. IcosavaxIcosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.United States$119M
  4. MMMemento MedicinesMemento Medicines is a biotech developing bispecific antibody therapies for eye diseases.United Kingdom$93M
  5. Areteia TherapeuticsAreteia Therapeutics, Inc.United States$75M
  6. i2o Therapeuticsi2o Therapeutics is a biotechnology company based in Boston, founded in 2019 by researchers from Harvard University.United States$46M
  7. NNeuroViaNeuroVia is a biopharmaceutical company.United States$14M

Pre-seed and seed

3 startups · $26M raised

  1. Avilar TherapeuticsAvilar Therapeutics is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2020.United States$15M
  2. Eligo BioscienceEligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.France$7.2M
  3. CurisiumInnovative Healthcare ContractingUnited States$3.5M

Growth

2 startups · $150M raised

  1. WDWarp Drive BioWarp Drive Bio develops genomic search engine and customized search queries that reveal hidden natural products based on genomic signature.Brazil$125M
  2. Graviton BioscienceBiotechnology, clinical stage, CNC, autoimmune, fibrotic indicationsUnited States$25M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Sanofi as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapSanofi portfolio map70 startups · $9.8BCo-investorsWho invests with Sanofi56 co-investorsInvestments abroadSanofi's investments in the United States55 startups · $7.0BSector portfolioY Combinator's AI portfolio1,143 startups · $44BSector portfolioY Combinator's Fintech portfolio338 startups · $24BSector portfolioTechstars' AI portfolio336 startups · $4.9B

Raising from investors like Sanofi?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps